$MATN Mateon Therapeutics (OTCQB: MATN) files a IND with US FDA to Evaluate its Antisense Drug Candidate OT-101 in COVID-19 patients

https://t.co/2qPHGKyaRt

$CYDY $AZN $BBIO $PFE $RHHBY $CANF $EPIX $MRK $GNCA $SYBX 

#CoronaVirus #Covid19 #Covid19Vaccine #Covid19Cure